Cargando…

Animal Models of Steatosis (NAFLD) and Steatohepatitis (NASH) Exhibit Hepatic Lobe-Specific Gelatinases Activity and Oxidative Stress

Animal models of obstructive cholestasis and ischemia/reperfusion damage have revealed the functional heterogeneity of liver lobes. This study evaluates this heterogeneity in nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) rat models. Twelve-week-old Obese and Lean m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Palladini, Giuseppina, Di Pasqua, Laura G., Berardo, Clarissa, Siciliano, Veronica, Richelmi, Plinio, Perlini, Stefano, Ferrigno, Andrea, Vairetti, Mariapia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378039/ https://www.ncbi.nlm.nih.gov/pubmed/30854350 http://dx.doi.org/10.1155/2019/5413461

Ejemplares similares

The selective blockade of metabotropic glutamate receptor-5 attenuates fat accumulation in an in vitro model of benign steatosis
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: Current Issues and Future Perspectives in Preclinical and Clinical Research
por: Berardo, Clarissa, et al.
Publicado: (2020)

MCD Diet Rat Model Induces Alterations in Zinc and Iron during NAFLD Progression from Steatosis to Steatohepatitis
por: Palladini, Giuseppina, et al.
Publicado: (2022)

Lobe-Specific Heterogeneity in Asymmetric Dimethylarginine and Matrix Metalloproteinase Levels in a Rat Model of Obstructive Cholestasis
por: Ferrigno, Andrea, et al.
Publicado: (2014)

Isolation of rat hepatocytes for pharmacological studies on metabotropic glutamate receptor (mGluR) subtype 5: a comparison between collagenase I versus collagenase IV
por: Berardo, Clarissa, et al.
Publicado: (2020)

Obeticholic acid reduces biliary and hepatic matrix metalloproteinases activity in rat hepatic ischemia/reperfusion injury
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Fatty Acid Desaturase Involvement in Non-Alcoholic Fatty Liver Disease Rat Models: Oxidative Stress Versus Metalloproteinases
por: Palladini, Giuseppina, et al.
Publicado: (2019)

Transient Expression of Reck Under Hepatic Ischemia/Reperfusion Conditions Is Associated with Mapk Signaling Pathways
por: Ferrigno, Andrea, et al.
Publicado: (2020)

Selective Blockade of the Metabotropic Glutamate Receptor mGluR5 Protects Mouse Livers in In Vitro and Ex Vivo Models of Ischemia Reperfusion Injury
por: Ferrigno, Andrea, et al.
Publicado: (2018)

Comparison between Lipofectamine RNAiMAX and GenMute transfection agents in two cellular models of human hepatoma
por: Berardo, Clarissa, et al.
Publicado: (2019)

Oxygen tension-independent protection against hypoxic cell killing in rat liver by low sodium
por: Ferrigno, Andrea, et al.
Publicado: (2017)

Localization and role of metabotropic glutamate receptors subtype 5 in the gastrointestinal tract
por: Ferrigno, Andrea, et al.
Publicado: (2017)

Changes in Glutathione Content in Liver Diseases: An Update
por: Vairetti, Mariapia, et al.
Publicado: (2021)

The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury
por: Ferrigno, Andrea, et al.
Publicado: (2018)

Associations between serum trace elements and inflammation in two animal models of nonalcoholic fatty liver disease
por: Palladini, Giuseppina, et al.
Publicado: (2020)

Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 2.0
por: Vairetti, Mariapia, et al.
Publicado: (2022)

Detailed Molecular Mechanisms Involved in Drug-Induced Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis: An Update
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2022)

Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile
por: Ferrigno, Andrea, et al.
Publicado: (2014)

Lung Matrix Metalloproteinase Activation following Partial Hepatic Ischemia/Reperfusion Injury in Rats
por: Palladini, Giuseppina, et al.
Publicado: (2014)

Liver Graft Susceptibility during Static Cold Storage and Dynamic Machine Perfusion: DCD versus Fatty Livers
por: Ferrigno, Andrea, et al.
Publicado: (2017)

Obeticholic Acid Reduces Kidney Matrix Metalloproteinase Activation Following Partial Hepatic Ischemia/Reperfusion Injury in Rats
por: Palladini, Giuseppina, et al.
Publicado: (2022)

Analysis of Massaciuccoli Peat after Maturation in Sodium Chloride Water of Undulna Thermae
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2022)

Serum and Hepatic Autofluorescence as a Real-Time Diagnostic Tool for Early Cholestasis Assessment
por: Croce, Anna C., et al.
Publicado: (2018)

Spectrofluorometric Analysis of Autofluorescing Components of Crude Serum from a Rat Liver Model of Ischemia and Reperfusion
por: Croce, Anna C., et al.
Publicado: (2020)

Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion
por: Croce, Anna C., et al.
Publicado: (2023)

Long-term cold storage preservation does not affect fatty livers from rats fed with a methionine and choline deficient diet
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2021)

Metabotropic Glutamate Receptor Blockade Reduces Preservation Damage in Livers from Donors after Cardiac Death
por: Di Pasqua, Laura Giuseppina, et al.
Publicado: (2021)

MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis Diagnosis
por: Segura-Azuara, Nancy de los Ángeles, et al.
Publicado: (2022)

MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice
por: Ferrigno, Andrea, et al.
Publicado: (2023)

Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
por: Campagnoli, Lucrezia Irene Maria, et al.
Publicado: (2022)

Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)
por: Drescher, Hannah K., et al.
Publicado: (2019)

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
por: Younossi, Zobair M., et al.
Publicado: (2023)

Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017)

The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

The Differential Expression of Cide Family Members is Associated with Nafld Progression from Steatosis to Steatohepatitis
por: Sans, Arnaud, et al.
Publicado: (2019)

MCD Diet Modulates HuR and Oxidative Stress-Related HuR Targets in Rats
por: Ferrigno, Andrea, et al.
Publicado: (2023)

Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021)

Evolving Role for Pharmacotherapy in NAFLD/NASH
por: Attia, Suzanna L., et al.
Publicado: (2020)

Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH)
por: Wu, Jiayu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_omodkb2mnnl55hjihnpuf70lli